Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials.
from CoinDesk http://bit.ly/2SrB5JI
Wednesday, 13 February 2019
Subscribe to:
Post Comments (Atom)
February 13, 2019 / in CoinDesk, Coins Feeds / with No comments /
0 comments:
Post a Comment